Recordati Industria Chimica E Farmaceutica (RCDTF) Stock Price, News & Analysis

Company Overview

Recordati Industria Chimica e Farmaceutica S.p.A. is an Italian pharmaceutical company focused on the research, development, manufacture and commercialization of medicines. Its activities are centered on specialty-care and rare-disease treatments, with products addressing areas such as endocrinology, oncology, urology, cardiology, gastroenterology and other specialized medical needs.

The company markets both proprietary and licensed medicines, serving patients through prescription products and therapies for uncommon or underserved conditions. Its rare-disease portfolio includes treatments for certain endocrine disorders and oncology-related conditions, while its broader specialty-care operations include established medicines distributed through its commercial organization and selected partnerships.

Founded in Milan in 1926, Recordati has expanded from an Italian pharmaceutical business into an international company. It serves markets across Europe and in other regions, including selected countries in the Middle East, North Africa, Turkey and the United States. The company operates through research, manufacturing and commercial activities supported by a network of subsidiaries and partners.

Key Stats

• Today's Range: $58.79 to $58.79
• 50-Day Range: $58.00 to $58.79
• 52-Week Range: $55.88 to $60.00
• Volume: N/A
• Average Volume: 169 shs
• Market Capitalization: $12.13 billion
• P/E Ratio: 20.97
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Buy

Recordati Industria Chimica E Farmaceutica Stock Analysis - MarketRank™

Recordati Industria Chimica E Farmaceutica scored higher than 28% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.5 / 5
• Analyst Rating: Buy

Consensus Rating

Recordati Industria Chimica E Farmaceutica has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 strong buy rating, no buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Recordati Industria Chimica E Farmaceutica has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Recordati Industria Chimica E Farmaceutica is 15.47, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 36.60.

Price to Earnings Ratio vs. Sector

The P/E ratio of Recordati Industria Chimica E Farmaceutica is 15.47, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 217.88.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.02% of the float of Recordati Industria Chimica E Farmaceutica has been sold short.

Short Interest Ratio / Days to Cover

Recordati Industria Chimica E Farmaceutica has a short interest ratio ("days to cover") of 999.99, which indicates bearish sentiment.

Change versus previous month

Short interest in Recordati Industria Chimica E Farmaceutica has recently decreased by 39.15%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Recordati Industria Chimica E Farmaceutica does not currently pay a dividend.

Dividend Growth

Recordati Industria Chimica E Farmaceutica does not have a long track record of dividend growth.

News and Social Media

• Score: 2.2 / 5
• News Sentiment: 0.50

News Sentiment

Recordati Industria Chimica E Farmaceutica has a news sentiment score of 0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.73 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Recordati Industria Chimica E Farmaceutica this week, compared to 0 articles on an average week.

Company Ownership

• Score: N/A
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Recordati Industria Chimica E Farmaceutica insiders have not sold or bought any company stock.

Percentage Held by Institutions

Recordati Industria Chimica E Farmaceutica has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 7/29/2026
• Today: 10/16/2026
• Next Earnings (Estimated): 11/10/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:RCDTF
• Previous Symbol: NASDAQ:RCDTF
• CIK: N/A
• Web: www.recordati.com
• Phone: 390-248-7871
• Fax: 39-02-4007-3747
• Employees: 4,693
• Year Founded: 1926

Profitability

• EPS (Trailing Twelve Months): $2.80
• Trailing P/E Ratio: 20.97
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $501.92 million
• Net Margins: 18.38%
• Pretax Margin: N/A
• Return on Equity: 33.73%
• Return on Assets: 12.76%

Debt

• Debt-to-Equity Ratio: 0.79
• Current Ratio: 1.26
• Quick Ratio: 0.86

Sales & Book Value

• Annual Sales: $2.96 billion
• Price / Sales: 4.10
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 206,300,000
• Free Float: N/A
• Market Cap: $12.13 billion
• Optionable: Not Optionable
• Beta: 0.26